Kathleen M Gura Selected Research

Therapeutics

1/2024	Inflammation drives pathogenesis of early intestinal failure-associated liver disease.
1/2023	Incidence and development of cholestasis in surgical neonates receiving an intravenous mixed-oil lipid emulsion.
1/2023	Ethanol lock therapy increases mechanical catheter complications in a pediatric intestinal failure population: A retrospective cohort study.
1/2022	Structurally-engineered fatty acid 1024 (SEFA-1024) improves diet-induced obesity, insulin resistance, and fatty liver disease.
12/2020	Optimizing Duration of Empiric Management of Suspected Central Line-Associated Bloodstream Infections in Pediatric Patients with Intestinal Failure.
11/2018	Innovative Discharge Process for Families with Pediatric Short Bowel Syndrome: A Prospective Nonrandomized Trial.
8/2018	A detailed guide to lipid therapy in intestinal failure.
1/2018	Parenteral Soybean Oil Induces Hepatosteatosis Despite Addition of Fish Oil in a Mouse Model of Intestinal Failure-Associated Liver Disease.
1/2017	Long-Term Fish Oil Lipid Emulsion Use in Children With Intestinal Failure-Associated Liver Disease [Formula: see text].
1/2016	Predictors of failure of fish-oil therapy for intestinal failure-associated liver disease in children.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kathleen M Gura Research Topics

Disease

49	Liver Diseases (Liver Disease) 04/2024 - 07/2006
37	Intestinal Failure 01/2024 - 07/2006
27	Cholestasis 01/2024 - 07/2006
9	Short Bowel Syndrome 11/2023 - 07/2006
6	Sepsis (Septicemia) 04/2024 - 07/2013
6	Inflammation (Inflammations) 01/2024 - 02/2011
6	Fibrosis (Cirrhosis) 01/2023 - 12/2006
5	Infections 01/2022 - 05/2004
3	Hemorrhage 01/2022 - 01/2016
3	Critical Illness (Critically Ill) 01/2021 - 01/2010
3	Hypertriglyceridemia 01/2019 - 03/2008
3	Disease Progression 01/2018 - 01/2015
3	End Stage Liver Disease 02/2016 - 01/2015
3	Metabolic Bone Diseases (Osteopenia) 11/2015 - 09/2013
2	Non-alcoholic Fatty Liver Disease 01/2022 - 01/2018
2	Fatty Liver 01/2022 - 12/2006
2	Weight Gain 01/2022 - 01/2017
2	Necrosis 01/2019 - 01/2018
2	Cytomegalovirus Infections (Inclusion Disease) 01/2019 - 12/2011
2	Dyslipidemias (Dyslipidemia) 09/2011 - 09/2010
1	Hypertensive Crisis 12/2023
1	Vomiting 11/2023
1	Diarrhea 11/2023
1	Abdominal Pain (Pain, Abdominal) 11/2023
1	Constipation 11/2023
1	Malnutrition (Nutritional Deficiencies) 01/2023
1	Congenital Diaphragmatic Hernias 12/2022
1	Mycoses (Diseases, Fungus) 01/2022
1	Body Weight (Weight, Body) 01/2022
1	Bronchopulmonary Dysplasia 01/2022
1	Insulin Resistance 01/2022
1	Obesity 01/2022
1	Weight Loss (Weight Reduction) 01/2022
1	Confusion (Bewilderment) 02/2021
1	Refeeding Syndrome 04/2020
1	Endotoxemia 11/2019
1	Pruritus (Itching) 01/2019
1	Reperfusion Injury 01/2018
1	Ischemia 01/2018
1	Vitamin D Deficiency 10/2017
1	Tachypnea 01/2017
1	Lethargy 01/2017

Drug/Important Bio-Agent (IBA)

35	Fish OilsIBA 01/2022 - 07/2006
30	EmulsionsIBA 01/2023 - 03/2008
28	LipidsIBA 01/2023 - 08/2009
16	Soybean Oil FDA LinkGeneric 01/2023 - 09/2009
13	Fatty Acids (Saturated Fatty Acids)IBA 11/2023 - 03/2008
12	Intravenous Fat EmulsionsIBA 01/2021 - 10/2005
10	BilirubinIBA 01/2024 - 03/2008
4	Triglycerides (Triacylglycerol)IBA 01/2023 - 12/2009
4	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 02/2011
4	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 12/2011 - 08/2006
3	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021 - 02/2011
3	fish oil triglyceridesIBA 02/2020 - 06/2010
2	Ethanol (Ethyl Alcohol)IBA 01/2023 - 02/2010
2	Phytosterols (Plant Sterols)IBA 01/2021 - 11/2013
2	Tocopherols (Tocopherol)IBA 01/2021 - 11/2013
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2020 - 02/2010
2	Essential Fatty AcidsIBA 01/2019 - 09/2015
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2017
2	Docosahexaenoic AcidsIBA 03/2017 - 08/2009
1	Selegiline (E250)FDA LinkGeneric 12/2023
1	TyramineIBA 12/2023
1	FatsIBA 10/2023
1	Lipase (Acid Lipase)FDA Link 10/2023
1	TransferasesIBA 01/2023
1	Heparin (Liquaemin)FDA LinkGeneric 01/2023
1	Keratin-7 (Cytokeratin 7)IBA 01/2023
1	EnzymesIBA 01/2022
1	ORALIT (ORS)IBA 01/2022
1	VitaminsIBA 01/2022
1	Eicosapentaenoic AcidIBA 01/2022
1	Vitamin K FDA Link 01/2020
1	Tumor Biomarkers (Tumor Markers)IBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2018
1	Saline SolutionIBA 01/2018
1	SeleniumIBA 10/2017
1	Trace Elements (Biometals)IBA 10/2017
1	IronIBA 10/2017
1	ZincIBA 10/2017
1	MicronutrientsIBA 10/2017

Therapy/Procedure

47	Parenteral Nutrition 04/2024 - 10/2005
17	Therapeutics 01/2024 - 10/2005
6	Enteral Nutrition (Feeding, Tube) 10/2023 - 02/2010
5	Catheters 01/2023 - 12/2009
4	Liver Transplantation 01/2021 - 07/2006
3	Transplantation 01/2018 - 01/2015
2	Drug Therapy (Chemotherapy) 11/2023 - 08/2006
2	Injections 02/2021 - 01/2017
2	Home Parenteral Nutrition 01/2021 - 11/2018
2	Central Venous Catheters 12/2020 - 05/2004
2	Total Parenteral Nutrition 09/2011 - 02/2011
1	Operative Surgical Procedures 11/2023
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 12/2022
1	Glycemic Control 01/2022
1	Nutritional Support (Artificial Feeding) 12/2020
1	Ketogenic Diet 11/2019
1	Nutrition Therapy (Medical Nutrition Therapy) 08/2018
1	Critical Care (Surgical Intensive Care) 10/2017